Response Genetics (RGDX +33.3%) ramps higher today after it announced earlier that it entered...

|About: Response Genetics, Inc. (RGDX)|By:, SA News Editor

Response Genetics (RGDX +33.3%) ramps higher today after it announced earlier that it entered into a purchase agreement with GlaxoSmithKline (GSK +1.7%) and one of its existing significant stockholders to raise $8.8M from the private placement of 8M newly issued shares at $1.10 per share.